<![CDATA[ First-Line Data From AMIGO-1 and COPERNICUS, EGFR Result in Central Nervous System Involvement, and KRAS G12C ...
The faculty discuss 2 first-line reports from the 2026 World Conference on Lung Cancer. For AMIGO-1, a single-arm phase 2 study adding pemetrexed to amivantamab and lazertinib, they weigh the efficacy signal against treatment-related deaths and the limits …